StockWatch
·

JAGSONPAL PHARMACEUTICALS LTD. Q3 FY26 Results

JAGSNPHARMQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue72.942.0%1.5%
Total Income75.922.0%0.6%
Expenditure59.322.2%2.5%
PBT14.5213.6%62.5%
Net Profit10.9512.9%65.8%
OPM19.45%2.62pp26.05pp
NPM14.42%1.81pp27.48pp
EPS1.6711.2%64.8%
View full financials

Informational and educational content only. Not investment advice.